Literature DB >> 18181942

Parthenotes as a source of embryonic stem cells.

T A L Brevini1, F Gandolfi.   

Abstract

The derivation and study of human embryonic stem cell lines, despite their potential therapeutic usefulness, raise considerable ethical, religious, legal and political concerns because it inevitably leads to the destruction of viable embryos. In an attempt to bridge the division between ethical questions and potential scientific and medical benefits, considerable efforts have been devoted to the search for alternative sources of pluripotent cell lines. In this review we discuss the use of artificial parthenogenesis as a way to create entities, called parthenotes, that may represent an alternative ethical source for pluripotent cell lines. We describe the biological differences between parthenotes and embryos, in order to provide a rationale for the discussion on whether their use can be acceptable as a source of stem cells. We present data derived from animal models on the extent parthenogenetic stem cells are similar to biparental cell lines and discuss these aspects in the context of their extension to the human species. Finally, we present experiments recently carried out in our laboratory that allowed us to generate human parthenotes through artificial activation of human oocytes and to use them as a source for the derivation of parthenogenetic pluripotent cell lines.

Entities:  

Mesh:

Year:  2008        PMID: 18181942      PMCID: PMC6496533          DOI: 10.1111/j.1365-2184.2008.00485.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  59 in total

1.  First meiosis errors in immature oocytes generated by stimulated cycles.

Authors:  M Cristina Magli; Anna P Ferraretti; Andor Crippa; Michela Lappi; Elisabetta Feliciani; Luca Gianaroli
Journal:  Fertil Steril       Date:  2006-06-21       Impact factor: 7.329

2.  Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research.

Authors:  A Rhoton-Vlasak; P Y Lu; K M Barud; G W Dewald; D G Hammitt
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

Review 3.  Derivation and characterization of pluripotent cell lines from pig embryos of different origins.

Authors:  Tiziana A L Brevini; Valentina Tosetti; Mattia Crestan; Stefania Antonini; Fulvio Gandolfi
Journal:  Theriogenology       Date:  2006-10-20       Impact factor: 2.740

4.  Dissociation between intracellular calcium elevation and development of human oocytes treated with calcium ionophore.

Authors:  P Rinaudo; J R Pepperell; S Buradgunta; M Massobrio; D L Keefe
Journal:  Fertil Steril       Date:  1997-12       Impact factor: 7.329

5.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

6.  Production of cloned pigs from cultured fetal fibroblast cells.

Authors:  Andrew C Boquest; Christopher G Grupen; Sharon J Harrison; Stephen M McIlfatrick; Rodney J Ashman; Anthony J F d'Apice; Mark B Nottle
Journal:  Biol Reprod       Date:  2002-05       Impact factor: 4.285

7.  The new Italian IVF legislation.

Authors:  Giuseppe Benagiano; Luca Gianaroli
Journal:  Reprod Biomed Online       Date:  2004-08       Impact factor: 3.828

8.  Parthenogenetic activation and development of fresh and aged human oocytes.

Authors:  N Winston; M Johnson; S Pickering; P Braude
Journal:  Fertil Steril       Date:  1991-11       Impact factor: 7.329

9.  Establishment of pluripotential cell lines from haploid mouse embryos.

Authors:  M H Kaufman; E J Robertson; A H Handyside; M J Evans
Journal:  J Embryol Exp Morphol       Date:  1983-02

10.  Stem cell defects in parthenogenetic peri-implantation embryos.

Authors:  E D Newman-Smith; Z Werb
Journal:  Development       Date:  1995-07       Impact factor: 6.868

View more
  19 in total

1.  Centrosome amplification and chromosomal instability in human and animal parthenogenetic cell lines.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Sara Maffei; Gianluca Tettamanti; Arianna Vanelli; Sara Isaac; Amir Eden; Sergio Ledda; Magda de Eguileor; Fulvio Gandolfi
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

2.  Parthenogenesis-derived multipotent stem cells adapted for tissue engineering applications.

Authors:  Chester J Koh; Dawn M Delo; Jang Won Lee; M Minhaj Siddiqui; Robert P Lanza; Shay Soker; James J Yoo; Anthony Atala
Journal:  Methods       Date:  2008-09-15       Impact factor: 3.608

3.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 4.  Cell therapy for the treatment of coronary heart disease: a critical appraisal.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Nat Rev Cardiol       Date:  2010-02-23       Impact factor: 32.419

5.  Quantitative proteomics analysis of parthenogenetically induced pluripotent stem cells.

Authors:  Zhe Hu; Lei Wang; Zhensheng Xie; Xinlei Zhang; Du Feng; Fang Wang; Bingfeng Zuo; Lingling Wang; Zhong Liu; Zhisheng Chen; Fuquan Yang; Lin Liu
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

6.  Parthenogenetic stem cells for tissue-engineered heart repair.

Authors:  Michael Didié; Peter Christalla; Michael Rubart; Vijayakumar Muppala; Stephan Döker; Bernhard Unsöld; Ali El-Armouche; Thomas Rau; Thomas Eschenhagen; Alexander P Schwoerer; Heimo Ehmke; Udo Schumacher; Sigrid Fuchs; Claudia Lange; Alexander Becker; Wen Tao; John A Scherschel; Mark H Soonpaa; Tao Yang; Qiong Lin; Martin Zenke; Dong-Wook Han; Hans R Schöler; Cornelia Rudolph; Doris Steinemann; Brigitte Schlegelberger; Steve Kattman; Alec Witty; Gordon Keller; Loren J Field; Wolfram-Hubertus Zimmermann
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

7.  Parthenogenic blastocysts derived from cumulus-free in vitro matured human oocytes.

Authors:  Sohyun L McElroy; James A Byrne; Shawn L Chavez; Barry Behr; Aaron J Hsueh; Lynn M Westphal; Renee A Reijo Pera
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

Review 8.  Parthenogenesis as an approach to pluripotency: advantages and limitations involved.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Stefania Antonini; Fulvio Gandolfi
Journal:  Stem Cell Rev       Date:  2008-06-12       Impact factor: 5.739

9.  Quo Vadis medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?

Authors:  Mariusz Z Ratajczak; Malwina Suszyńska
Journal:  Acta Haematol Pol       Date:  2013-07

10.  Pluripotent stem cell derived cardiomyocytes for cardiac repair.

Authors:  Scott D Lundy; Jay A Gantz; Chelsea M Pagan; Dominic Filice; Michael A Laflamme
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.